Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Jun-23 4:45 PM View:  | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Disposition (change in control) | 5,914,250 | $0.91 | $5,381,970.00 | (100%) 5.91M to 0 | |
| 21-Jun-21 5:31 PM View: | Kala Bio, Inc. (KALA) | 17-Jun-21 | Grant | 20,000 | -- | -- | < 1% 10.89M to 10.91M | |
| 21-May-21 5:52 PM View: | Black Diamond Therapeutics,... (BDTX) | 20-May-21 | Disposition (other) | 443 | $24.01 | $10,636.40 | (< 1%) 2.59M to 2.59M | |
| 05-Apr-21 4:34 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Apr-21 | Acquisition (other) | 353,814 | $24.26 | $8,583,530.00 | 18% 1.92M to 2.28M | 5% |
| 22-Mar-21 8:25 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Mar-21 | Grant | 443 | $24.01 | $10,636.40 | < 1% 2.59M to 2.59M | 5% |
| 14-Dec-20 8:33 PM View: | Solid Biosciences Inc. (SLDB) | 10-Dec-20 | Grant | 4,938,280 | $3.70 | $18,271,600.00 | 131% 3.77M to 8.71M | 85% |
| 30-Jun-20 10:00 PM View: | Kala Bio, Inc. (KALA) | 25-Jun-20 | Grant | 20,000 | -- | -- | < 1% 10.87M to 10.89M | |
| 03-Apr-20 9:00 AM View: | Ra Pharmaceuticals, Inc. (RARX) | 02-Apr-20 | Disposition Duplicate | 4,858,260 | $48.00 | $233,196,000.00 | (100%) 4.86M to 0 | |
| 13-Mar-20 6:47 PM View: | Kala Bio, Inc. (KALA) | 13-Mar-20 | Market Purchase Duplicate | 6,337,140 | $7.89 | $50,000,000.00 | 140% 4.54M to 10.87M | |
| 05-Feb-20 5:58 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Conversion | 1,589,900 | -- | -- | 100% 0 to 1.59M | |
| 05-Feb-20 5:58 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Purchase | 1,000,000 | $19.00 | $19,000,000.00 | 63% 1.59M to 2.59M | |
| 17-Sep-19 4:05 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 17-Sep-19 | Conversion | 3,348,520 | -- | -- | 100% 0 to 3.35M | |
| 17-Sep-19 4:05 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 17-Sep-19 | Purchase | 1,333,330 | $15.00 | $20,000,000.00 | 40% 3.35M to 4.68M | |
| 29-Jul-19 4:32 PM View: | Solid Biosciences Inc. (SLDB) | 25-Jul-19 | Grant | 1,881,720 | $4.65 | $8,750,000.00 | 70% 2.69M to 4.57M | 47% |
| 14-Dec-18 6:14 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 14-Dec-18 | Market Purchase | 1,006,450 | $15.50 | $15,600,000.00 | 26% 3.85M to 4.86M | 29% |
| 05-Oct-18 4:34 PM View: | Kala Bio, Inc. (KALA) | 03-Oct-18 | Market Purchase Duplicate | 2,424,240 | $8.25 | $20,000,000.00 | 115% 2.11M to 4.54M | (13%) |
| 22-Jun-18 7:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 22-Jun-18 | Conversion | 1,103,850 | -- | -- | 100% 0 to 1.1M | |
| 22-Jun-18 7:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 22-Jun-18 | Purchase | 1,058,820 | $17.00 | $18,000,000.00 | 96% 1.1M to 2.16M | |
| 16-Feb-18 4:42 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 14-Feb-18 | Market Purchase Duplicate | 2,500,000 | $6.00 | $15,000,000.00 | 185% 1.35M to 3.85M | 234% |
| 30-Jan-18 5:43 PM View: | Solid Biosciences Inc. (SLDB) | 30-Jan-18 | Purchase | 1,000,000 | $16.00 | $16,000,000.00 | 59% 1.69M to 2.69M | |
| 16-Oct-17 4:31 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 12-Oct-17 | Private Purchase | 850,000 | $8.50 | $7,225,000.00 | 144% 591.07K to 1.44M | |
| 26-Jul-17 4:31 PM View: | Kala Bio, Inc. (KALA) | 25-Jul-17 | Conversion | 1,579,900 | -- | -- | 100% 1.58M to 3.16M | |
| 26-Jul-17 4:31 PM View: | Kala Bio, Inc. (KALA) | 25-Jul-17 | Purchase | 533,333 | $15.00 | $8,000,000.00 | 17% 3.16M to 3.69M | |
| 23-Nov-16 7:51 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 21-Nov-16 | Grant Duplicate | 591,070 | -- | -- | 100% 0 to 591.07K | |
| 31-Oct-16 8:46 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Conversion Duplicate | 1,190,270 | -- | -- | 193% 616.65K to 1.81M | |
| 31-Oct-16 8:46 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Purchase Duplicate | 161,538 | $13.00 | $2,099,990.00 | 9% 1.81M to 1.97M |